Depression in pregnancy

Depression in pregnancy, also known as antenatal depression, is a mood disorder characterized by persistent feelings of sadness, loss of interest, hopelessness, and impaired functioning occurring during pregnancy. It is one of the most common mental health disorders affecting pregnant women and may have significant consequences for both maternal and fetal health if left untreated.

Depression during pregnancy can adversely affect maternal self-care, nutrition, adherence to antenatal care, and preparation for motherhood. It is also associated with adverse pregnancy outcomes and may contribute to postpartum depression and developmental problems in the child. Early identification and appropriate management are therefore essential components of comprehensive antenatal care.

Epidemiology

Depression is among the most common psychiatric disorders during pregnancy. It can occur at any stage of gestation and ranges from mild depressive symptoms to severe major depressive disorder. Women with a previous history of depression or other mood disorders are at particularly high risk.

Risk Factors

Biological and clinical risk factors

• Previous history of depression

• Previous history of postpartum depression

• Family history of depression

• Discontinuation of antidepressant medication in women with a history of depression

• Previous psychiatric illness

• Chronic medical illnesses

• Substance use disorders

• Hormonal and neurochemical changes associated with pregnancy

Psychosocial Risk Factors

• Negative attitude toward the pregnancy

• Unplanned or unwanted pregnancy

• Lack of social support

• Maternal stress associated with adverse life events

• Marital or relationship difficulties

• Financial hardship

• Domestic violence

• Partner or family member who is unhappy about the pregnancy

• Social isolation

Pathophysiology

The development of depression during pregnancy is multifactorial and involves interactions between biological, psychological, and social factors.

Potential mechanisms include:

• Alterations in serotonin, norepinephrine, and dopamine neurotransmission

• Hormonal fluctuations involving estrogen and progesterone

• Dysregulation of the hypothalamic-pituitary-adrenal axis

• Genetic susceptibility

• Psychosocial stressors

• Previous psychiatric illness

The relationship between maternal depression and early childhood problems may form part of a sequence beginning with depressive symptoms during pregnancy and extending into the postpartum period.

Clinical Presentation

Depression in pregnancy may develop gradually or abruptly and may be difficult to distinguish from normal physiological changes of pregnancy.

Symptoms

• Persistent sadness or low mood

• Loss of interest or pleasure in usual activities

• Excessive crying

• Fatigue and low energy

• Feelings of hopelessness

• Feelings of worthlessness or excessive guilt

• Poor concentration

• Indecisiveness

• Anxiety and excessive worry

• Sleep disturbances

• Appetite changes

• Social withdrawal

• Irritability

• Recurrent thoughts of death or suicide

Clinical Signs

• Depressed affect

• Reduced eye contact

• Psychomotor retardation or agitation

• Poor self-care

• Tearfulness during consultation

• Reduced participation in antenatal care

• Impaired social functioning

Differential Diagnosis

The following conditions should be considered before confirming a diagnosis of depression during pregnancy:

Psychiatric Conditions

• Adjustment disorder

• Generalized anxiety disorder

• Panic disorder

• Bipolar affective disorder

• Persistent depressive disorder (dysthymia)

• Post-traumatic stress disorder

• Substance-induced mood disorder

• Psychotic disorders

Medical Conditions

• Hypothyroidism

• Hyperthyroidism

• Iron deficiency anaemia

• Vitamin B12 deficiency

• Chronic infections

• Systemic lupus erythematosus

• Medication-induced mood changes

Pregnancy-Related Conditions

• Normal emotional changes of pregnancy

• Hyperemesis gravidarum associated with fatigue and low mood

• Sleep disorders associated with pregnancy

Diagnostic Criteria

Diagnosis is based on the presence of depressive symptoms lasting at least two weeks and causing significant distress or impairment in social, occupational, or daily functioning.

Core features include:

• Persistent depressed mood, and/or

• Markedly diminished interest or pleasure in activities

Accompanied by several of the following:

• Sleep disturbances

• Appetite changes

• Fatigue

• Feelings of worthlessness or guilt

• Impaired concentration

• Psychomotor changes

• Suicidal thoughts or behavior

A comprehensive psychiatric assessment should be performed to determine severity and identify risks to the mother and fetus.

Investigations

Laboratory investigations

Investigations may be required to exclude medical causes of depressive symptoms:

• Full blood count

• Thyroid function tests

• Blood glucose assessment

• Serum vitamin B12 level where indicated

• Renal function tests where indicated

• Liver function tests where indicated

Mental Health assessment

• Comprehensive psychiatric evaluation

• Assessment of severity of depression

• Suicide risk assessment

• Assessment of psychosocial stressors

• Evaluation of social support systems

Management

Management should be individualized according to symptom severity, gestational age, previous psychiatric history, patient preference, and available support systems.

The goals of treatment are to:

• Relieve depressive symptoms

• Improve maternal functioning

• Promote healthy pregnancy outcomes

• Prevent relapse

• Reduce the risk of postpartum depression

Non-pharmacological treatment

Non-pharmacological interventions are recommended for all patients and may be sufficient for mild to moderate depression.

Psychotherapy

Cognitive Behavioral Therapy (CBT)

• Helps patients identify and modify negative thoughts and behaviors

• Improves coping skills and problem-solving abilities

• Reduces depressive symptoms and relapse risk

Interpersonal Psychotherapy (IPT)

• Addresses interpersonal conflicts and social difficulties

• Focuses on role transitions associated with pregnancy

• Strengthens social support networks

Education and support

• Provide information regarding depression during pregnancy

• Reassure the patient that effective treatment is available

• Encourage family involvement where appropriate

• Promote healthy lifestyle practices

• Encourage attendance at antenatal clinics

• Strengthen social support systems

Pharmacological Treatment

Pharmacological treatment may be considered for moderate to severe depression, recurrent depression, or when non-pharmacological interventions alone are insufficient.

Before initiating medication, the risks and benefits should be carefully discussed with the patient and, where possible, her partner.

Use one of the following:

• Amitriptyline (PO) 12.5–75 mg once daily at night, increase gradually to a maximum of 150 mg daily.

  Elderly: Initially 12.5–50 mg. Maximum dose 75 mg daily.

OR

• Citalopram (PO) 10–60 mg once daily in the morning or evening. Symptoms should be monitored and medication tapered appropriately when discontinuing treatment.

OR

• Fluoxetine (PO) 20–60 mg once daily in the morning.

Principles of pharmacological treatment

• Discuss potential risks and benefits before treatment initiation.

• Obtain informed consent whenever possible.

• Start with the lowest effective dose.

• Monitor clinical response regularly.

• Monitor adherence and adverse effects.

• Avoid abrupt discontinuation of antidepressants.

• Taper medications gradually when discontinuation is indicated.

Management According to Severity

Mild depression

• Psychoeducation

• Cognitive behavioral therapy

• Interpersonal psychotherapy

• Social support interventions

• Close follow-up

Moderate depression

• Structured psychotherapy

• Consider antidepressant medication if symptoms persist or worsen

• Regular psychiatric review

Severe depression

• Combined psychotherapy and pharmacological treatment

• Urgent psychiatric assessment

• Suicide risk assessment

• Consider inpatient care if significant risk is present

Referral

Refer the patient to a psychiatrist or specialist mental health service when:

• Depression is severe

• There is suicidal ideation or suicidal behavior

• Psychotic symptoms are present

• Bipolar disorder is suspected

• There is poor response to treatment

• Complex psychiatric comorbidity exists

• Specialist perinatal mental health care is required

Complications

Maternal complications

• Poor antenatal care attendance

• Poor nutrition

• Substance misuse

• Self-harm

• Suicide

• Increased risk of postpartum depression

• Impaired maternal functioning

Fetal and neonatal complications

• Preterm birth

• Low birth weight

• Impaired mother-infant bonding

• Developmental and behavioral problems during childhood

Prognosis

The prognosis is generally good when depression is identified early and managed appropriately. Women receiving timely psychosocial and medical interventions often experience substantial symptom improvement and better pregnancy outcomes.

Untreated depression may persist into the postpartum period and adversely affect maternal and child health.

Prevention

• Early screening during antenatal care

• Identification of high-risk women

• Prompt management of previous depressive disorders

• Strengthening family and community support

• Stress reduction strategies

• Early referral for psychological support

• Regular antenatal follow-up

Special considerations

• Full disclosure of both the risks and benefits of antidepressant treatment should be provided to the patient and, where possible, her partner before initiating pharmacological therapy.

• Low doses of antidepressants should be considered when starting treatment and titrated according to clinical response.

• The decision to use medication should balance the potential risks of treatment against the risks associated with untreated maternal depression.

• Close collaboration between obstetric and mental health services is recommended for women with moderate to severe depression.